Institutional members access full text with Ovid®

Share this article on:

Pregnancy After Organ Transplantation: A Report From the U.K. Transplant Pregnancy Registry

Sibanda, Nokuthaba1; Briggs, J Douglas2; Davison, John M.3; Johnson, Rachel J.2; Rudge, Chris J.2,4

doi: 10.1097/
Original Articles: Clinical Transplantation

Background. Maternal and fetal complications in pregnancies after renal transplantation have been highlighted in several reports, but information on their main predisposing factors is limited. The U.K. Transplant Pregnancy Registry was established in 1997 to obtain detailed information on pregnancies in female organ transplant recipients across the U.K.

Methods. For each female kidney, liver, or cardiothoracic organ transplant recipient who had had a recent pregnancy, data on maternal and fetal factors and pregnancy outcomes were collected using forms completed by their transplant follow-up and obstetric units. For kidney transplant recipients, the factors that influence pregnancy outcome were studied using logistic regression, and the effect of pregnancy on graft function was analyzed.

Results. There were live births in 83%, 69%, and 79% of pregnancies in cardiothoracic organ, liver, and kidney recipients, respectively. In 50% of live births from renal patients, delivery was preterm (<37 weeks), with 83% of the preterm infants delivered via caesarean. Preterm delivery was associated with maternal drug-treated hypertension and impaired renal function. A matched case–control study showed no evidence of increased renal allograft loss after pregnancy. A univariate survival analysis, however, suggested an association between drug-treated hypertension during pregnancy and poorer postpregnancy graft survival. In patients with prepregnancy serum creatinine (SCr) >150 μmol/L, a trend toward increased postpregnancy SCr was identified.

Conclusions. Pregnancy is likely to end in a live birth in a majority of organ transplant recipients. In patients with greater prepregnancy SCr and/or drug-treated hypertension during pregnancy, however, subsequent renal function may be adversely affected.

1 Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom.

2 U.K. Transplant, NHS Blood and Transplant, Bristol, United Kingdom.

3 Directorate of Women’s Services, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.

On behalf of the UK Transplant Pregnancy Registry, UK Transplant, Bristol, United Kingdom.

4 Address for correspondence to: Chris J. Rudge, FRCS, U.K. Transplant, Fox Den Road, Bristol, BS34 8RR, United Kingdom.


Received 9 September 2006. Revision requested 9 October 2006.

Accepted 15 February 2007.

© 2007 Lippincott Williams & Wilkins, Inc.